Save Our Swings

Tempus’s Eric Lefkofsky

Health information technology as an industry is on the verge of revolutionary breakthroughs. Health care is innovating the way we use technology to deliver a customized healthcare care plan. Technological tools has enable us the ability create customized healthcare plans, specific to the needs of each induvial patient. Tempus, a healthcare analytical company based in Chicago IL, is taking an “outside” box approach in the way it is fighting cancer. Eric Lefkofsky, cofounder of Tempus discussed the recent success in securing investors funding dating back to 2015. Mr. Eric Lefkofsky said, one of the advantages Tempus had during its initial startup phase was having access to Eric’s funding. Eric Lefkofsky is also the cofounder of Groupon, and Mr. Lefkofsky initial investment in Tempus using his own money gave the health information technology company the financial freedom to really focus on research.

In September 2015, during the Series A Round, of the early stage venture Tempus secured $ 10 million in investments. June 2016, during the Series B Round, Tempus received $ 10 million. November 2016, Tempus received $ 10 million in investments during the Series B Round. In 2017, in April during the Series B Round, Tempus was the recipient of $ 30 million, and by September the same year, Tempus has received $ 70 million during the Series Round C. The $ 70 million investment during the Series Round C, was from New Enterprise Associates, and Revolutionary Growth. Tempus is currently valued to be worth $ 1.1 billion, making it officially a “Unicorn” startup company. Eric Lefkofsky, explained the recent large investments are due in large part to the understanding the potentially new discoveries in the health information technology. Currently for the first time in history we have access to very large, organized sets of data. Eric Lefkofsky believes, there are potential invaluable healthcare information in these data sets.

Tempus uses the power of data analytics, to help identify effective treatment procedures that can be applied to current cancer patients. Tempus creates a personalized cancer treatment roadmap, based on the patient’s unique needs.

To Know More Click Here

The Man Behind Tempus: Eric Lefkofsky

The technology start-up was co-founded by Eric Lefkofsky in 2015. So far, the company has raised at least $130 million in funding. These funds will support their groundbreaking technology that solves a big problem in the analysis and treatment of cancer.

Eric Lefkofsky grew up in Michigan. His father was an engineer, and the mother was a teacher. He attended Tamarack Camps where he grew into a leader and later worked as a staff member.

Later, he joined Michigan University and studied law. He graduated with honors from the institution in 1991. His educational pursuits did not end there; he advanced to the school of law at the University of Michigan and received his Doctor of Jurisprudence in1993. His entrepreneurial spirit saw him establish a myriad of start-up companies before Tempus.

Apart from being the head figure at the Tempus, Eric takes part in several charity organizations such as World Business Chicago, the Museum of Science and Industry, and the Lurie Children’s Hospital in Chicago.

Together with his wife, Eric co-founded the Lefkofsky Family Foundation, which supports education, human rights, art and culture, and healthcare needs of beneficiaries.

Under his leadership, Tempus has earned approval from the FDA for the use of its technology in treatment of cancer. Eric Lefkofsky believes that Tempus holds the key to the future of cancer treatment.

His team comprises of over 150 specialists in genetics, immunity, data scientists and engineers who are working towards the betterment of this disruptive technology.

Currently, Eric Lefkofsky is an adjunct professor at the University of Chicago’s business school. He is the author of ‘Accelerated Disruption: Understanding the True Speed of Innovation.’

The book provides insight on how technology has the potential to provide solutions to humanity’s problems, just like in the case of Tempus Technologies.

To Learn More Click Here

Scroll To Top